High-performance liquid chromatographic determination of pyridostigmine bromide, nicotine, and their metabolites in rat plasma and urine

Journal of Chromatographic Science

Volumn 39, Issue 7, 2001, Pages 287-292

  Abu Qare, Aqel W ^a   Abou Donia, Mohamed B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE DERIVATIVE; METHANOL; NICOTINE; PYRIDOSTIGMINE;

ARTICLE; DIAGNOSTIC ACCURACY; DRUG DETERMINATION; DRUG URINE LEVEL; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; URINALYSIS;

EID: 0035412273     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/39.7.287     Document Type: Article

References (30)

1. Clinical pharmacokinetics of cholinesterase inhibitors
2. Safety and efficacy of DEET and permethrin in the prevention of arthropod attack
3. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin: Implications of Gulf War chemicals exposure
4. The air we breathe
5. Method for isolation and determination of pyridostigmine and metabolites in urine and blood
6. The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium
7. Radioimmunoassay of pyridostigmine in plasma and tissues
8. High-performance liquid chromatographic determination of pyridostgmine in plasma
9. 14C]-pyridostigmine in the rat
10. Pyridostigmine metabolism in man
11. Plasma concentration of pyridostigmine during the antagonism of neuromuscular block
12. Metabolites of neostigmine and pyridostigmine do not contribute to antagonism of neuromuscular blockade in the dog
13. Oxidative stress induced by environmental tobacco smoke in the workplace is mitigated by antioxidant supplementation
14. Markers for cytogenetic damage in smokers: Associations with plasma antioxidants and glutathione S-transferase mu
15. Metabolism of nicotine
16. Rapid method for the simultaneous measurement of nicotine and cotinine in urine and serum by gas chromatography-mass spectrometry
17. Improved highly sensitive method for determination of nicotine and cotinine in human plasma by high-performance liquid chromatography
18. A simple high performance liquid chromatographic method for the quantification of total cotinine, total 3-hydroxycotinine and caffeine in the plasma of smokers
19. High-performance liquid chromatographic determination of cotinine in urine in isocratic mode
20. Rapid and sensitive high-performance liquid chromatographic determination of nicotine and cotinine in nonsmokers human and rat urines
21. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry
22. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography-tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers
23. Analysis of nicotine, 3-hydroxycotinine, cotinine, and caffeine in urine of passive smokers by HPLC-tandem mass spectrometry
24. Plasma clearance of neostigmine and pyridostigmine in the dog
25. GC determination of nicotine in subcutaneous adipose tissue obtained by minimal trauma tissue biopsy
26. A new gas chromatography-mass spectrometry method for simultaneous determination of total and free trans-3-hydroxycotinine and cotinine in the urine of subjects receiving trandermal nicotine
27. Increasing urinary cotinine concentrations at elevated temperatures: The role of conjugated metabolites
28. Quantitative gas-liquid chromatographic method for the determination of neostigmine and pyridostigmine in human plasma